Trial Profile
Efficacy of dolutegravir and rilpivirine in fully suppressed HIV infected patients with multiple virological failures
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 21 Oct 2016
Price :
$35
*
At a glance
- Drugs Dolutegravir (Primary) ; Rilpivirine (Primary)
- Indications HIV infections; HIV-1 infections
- Focus Therapeutic Use
- 21 Oct 2016 New trial record